Proopiomelanocortin (POMC) is the prohormone polyprotein of the pituitary and hypothalamus: a 241-residue precursor cut by prohormone convertases (PC1/3, PC2) into ACTH, the melanocyte-stimulating hormones (α-, β-, γ-MSH), β-endorphin, and β-lipotropin — the cutting map differing by tissue, so the anterior lobe ships ACTH while the hypothalamic neurons ship MSH peptides that suppress appetite. POMC-neuron loss and POMC mutations cause the most severe inherited obesity — the leptin-melanocortin axis's central node, targetable (setmelanotide) when broken.
Anterior and intermediate pituitary; hypothalamic arcuate neurons
Structure
241 aa precursor with paired-basic cleavage sites; products include ACTH (39 aa), α-MSH (13), β-endorphin (31)
Binding Partners
PC1/3 and PC2 convertases, carboxypeptidase E, MC1R–MC5R and opioid receptors (products)
Structure
Pairs of basic residues (KR, RR) punctuate the precursor — the convertases' recognition sites; each tissue's enzyme set decides which fragments accumulate.
Further processing (C-terminal amidation, N-terminal acetylation by POMC-modifying enzymes) activates α-MSH and inactivates β-endorphin's opioid activity respectively.
The ACTH segment internally contains α-MSH — a peptide within a peptide, the prohormone's Russian-doll design.
Function
Stress axis: corticotrope POMC → ACTH → adrenal cortisol — the hypothalamic-pituitary-adrenal limb; see CRH upstream and cortisol downstream.
Energy balance: arcuate POMC neurons' α-MSH acts on MC4R receptors to reduce appetite and raise expenditure — leptin's second messenger cell; AGRP/NPY neurons oppose them.
Pigmentation and analgesia: α-MSH on MC1R for melanin; β-endorphin on µ-opioid receptors — the prohormone's peripheral and central outputs.
Regulation
CRH and vasopressin induce pituitary POMC transcription; glucocorticoids repress it — the axis's feedback loop written at the gene.
Leptin and insulin signal to arcuate POMC neurons (STAT3 and PI3K routes — see Akt); ghrelin and endocannabinoids inhibit them — the first-order appetite integrator.
Circadian and ultradian pulses (the cortisol pulse generator) ride on POMC's regulated secretion.
Interactions
With PC1/3 deficiency: POMC and proinsulin both uncleaved — the combined obesity, diabetes, and hypoadrenalism syndrome that recombinant leptin partially treats.
With MC4R: the POMC-melanocortin circuit's receptor — MC4R mutations are the commonest monogenic obesity; setmelanotide is the MC4R agonist that replaces the missing signal, see leptin-axis therapies.
With the skin: POMC's UV-inducible expression in keratinocytes drives the tanning response via α-MSH-MC1R — a pigmentary endocrine loop.
Clinical Relevance
Genetic obesity: POMC-null patients — hyperphagia, early severe obesity, adrenal insufficiency, red hair; setmelanotide's approved indication.
Endocrine tumors: ectopic ACTH from small-cell lung cancer and bronchial carcinoids drives Cushing's — POMC expression as the tumor's signature.
Psychiatry and addiction: β-endorphin and MSH fragments' central roles — from naltrexone's opioid blockade to melanocortin-modulating experiments.